World Health Organization (WHO)
-
WHO backs three experimental drugs for Bundibugyo Ebola outbreak
The latest recommendations come as health authorities continue to battle a widening outbreak in eastern DRC, with additional confirmed cases reported in Uganda.
-
Global Climate and Health Alliance urges WHO to integrate climate action into global health policies
The appeal followed discussions held during the 79th World Health Assembly (WHA79), where climate-related health risks featured prominently across several agenda items.
-
African leaders mobilizes regional response to Bundibugyo Ebola outbreak
The leaders also pledged to protect essential services such as education, routine healthcare, cholera control and measles response efforts as countries confront the growing public health threat.
-
WHO signs landmark regulatory cooperation agreement with African Medicines Agency at WHA79
Through the new framework, WHO and AMA will coordinate efforts to streamline approval processes, enhance post-market surveillance, and build regulatory workforce capacity.
-
Kenya receives WHO certification for eliminating sleeping sickness in Geneva
WHO validated the elimination in June 2025, and Kenya made a national announcement in August 2025 before formally receiving the certification in Geneva.
-
WHO renews five-year partnership with Gilead Sciences to eliminate deadly Kala-Azar disease
Since the partnership began, Gilead has supplied more than 1.1 million vials of AmBisome and contributed over US$18 million in funding.
-
WHO declares Ebola global health emergency in DRC, Uganda
Health authorities in DRC and Uganda have already activated emergency response mechanisms, including contact tracing, case isolation, infection prevention measures, and enhanced treatment services.
-
COHSASA intensifies healthcare quality drive as WHO warns 2030 SDG targets are off track
Globally, new HIV infections declined by 40% between 2010 and 2024, while the number of people requiring interventions for neglected tropical diseases dropped by 36% during the same period.
-
WHO validates Australia as first high-income nation to eliminate trachoma
The achievement places Australia among 63 countries globally and 16 in the WHO Western Pacific Region that have eliminated at least one NTD.
-
Sam Pharmaceutical opens WHO-GMP facility in Nigeria to increase local drug production
The project received financial backing from First City Monument Bank (FCMB) and the Bank of Industry (BoI), reflecting a coordinated push to support local industry growth.